IRCT20200328046886N6招募中2 期
Evaluation of the efficacy and safety of colchicine in the prevention for post-CABG atrial fibrillation: a randomized double-blind placebo- controlled trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 172
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years(—)
- 性别
- All
入选标准
- •Patient between 18_80 years old
- •Patient with CAD and candidate for CABG
排除标准
- •Preoperative AF
- •Patients with pacemakers
- •Patient with Clcr<30ml/min
- •Severe hepatic insufficiency or transaminase level more than 3 times higher than normal
- •Breastfeeding or pregnancy
- •Colchicine intolerance or allergy
- •Lack of patients consent to participate in study
- •Presences of sick Sinus syndrom
- •Previous cardiac rhythm disorder,conduction blocks of any degree
- •Co administration with strong pgp and 3A4 inhibitors (voiconazol,ketoconazole,fluconazole,itraconazole,clarithromycin,etc.)
- •Taking anti arrhythmic medicines except beta blockers during past months of surgery
研究者
相似试验
招募中
2 期
Efficacy of Colchicine in Treatment of Covid-19Covid 19.Coronavirus as the cause of diseases classified elsewhereB97.2IRCT20201229049872N1Artesh University of Medical Sciences80
已完成
2 期
Colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19COVID-19.COVID-19, virus identifiedU07.1IRCT20200325046854N2Iran University of Medical Sciences70
招募中
2 期
Effect of Colchicine on aphthous ulceration.Aphthous.Recurrent oral aphthaeK12.0IRCT20160920029889N4Mazandaran University of Medical Sciences10
招募中
3 期
Evaluation of colchicine in treatment of coronavirusPulmonary infection of COVD19.Coronavirus infection, unspecifiedB34.2IRCT20200418047126N1Ardabil University of Medical Sciences100
进行中(未招募)
1 期
Evaluation of the efficacy of colchicine with and without betamethasone mouthwash in the management of recurrent aphthous stomatitis - ART1Recurrent aphthous stomatitis (RAS)EUCTR2006-003327-36-GBGuy's & St Thomas' NHS Foundation Trust136
